The continued imperative to protect U.S. innovation worldwide
TheCOVID-19 pandemic is further demonstrating that the world needs biopharmaceutical innovation to addresspressing global health challenges– both now and in the future. PhRMA members are collaborating with others andworking around the clock to research and develop vaccines and treatments to beat the virus.
Source: The Catalyst - Category: Pharmaceuticals Authors: Chris Moore Tags: Patents Intellectual Property Trade International Reference Pricing Source Type: news